{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:20:56Z","timestamp":1791580856801,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00415-019-09324-x","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T08:41:55Z","timestamp":1555317715000},"page":"1727-1735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Motor, cognitive and behavioral differences in MDS PSP phenotypes"],"prefix":"10.1007","volume":"266","author":[{"name":"The PSP Salerno study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Picillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Cuoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Tepedino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Cappiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Erro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Pellecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"issue":"7","key":"9324_CR1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","volume":"16","author":"AL Boxer","year":"2017","unstructured":"Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, H\u00f6glinger GU (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16(7):552\u2013563","journal-title":"Lancet Neurol"},{"issue":"1","key":"9324_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell B et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-PSP international workshop. Neurology 47(1):1\u20139","journal-title":"Neurology"},{"issue":"6","key":"9324_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria. Mov Disord 32(6):853\u2013864","journal-title":"Mov Disord"},{"issue":"11","key":"9324_CR4","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1007\/s00415-018-9038-x","volume":"265","author":"G Santangelo","year":"2018","unstructured":"Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M (2018) Comparative cognitive and neuropsychiatric profiles between Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy. J Neurol 265(11):2602\u20132613","journal-title":"J Neurol"},{"issue":"7","key":"9324_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/arclin\/acx093","volume":"32","author":"A Gerstnecker","year":"2017","unstructured":"Gerstnecker A (2017) The neuropsychology (broadly conceived) of multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Arch Clin Neuropsychol 32(7):861\u2013875","journal-title":"Arch Clin Neuropsychol"},{"issue":"6","key":"9324_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000479110","volume":"17","author":"A Pilotto","year":"2017","unstructured":"Pilotto A, Gazzina S, Benussi A et al (2017) Mild cognitive impairment and progression to dementia in progressive supranuclear palsy. Neurodegener Dis 17(6):286\u2013291","journal-title":"Neurodegener Dis"},{"issue":"2","key":"9324_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/arclin\/acs098","volume":"28","author":"A Gerstenecker","year":"2013","unstructured":"Gerstenecker A, Mast B, Duff K, Ferman TJ (2013) Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Arch Clin Neuropsychol 28(2):104\u2013113","journal-title":"Arch Clin Neuropsychol"},{"issue":"2","key":"9324_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/mds.20707","volume":"21","author":"D Millar","year":"2016","unstructured":"Millar D, Griffiths P, Zermansky AJ, Burn DJ (2016) Characterizing behavioural and cognitive dysexecutive changes in progressive supranuclear palsy. Mov Disord 21(2):199\u2013207","journal-title":"Mov Disord"},{"issue":"8","key":"9324_CR9","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/brain\/awq158","volume":"133","author":"RG Brown","year":"2010","unstructured":"Brown RG, Lacomblez L, Landwehrmeyer BG et al (2010) Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 133(8):2382\u20132393","journal-title":"Brain"},{"issue":"4","key":"9324_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/brain\/awf082","volume":"125","author":"N Cordato","year":"2002","unstructured":"Cordato N, Pantelis C, Halliday GM et al (2002) Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 125(4):789\u2013800","journal-title":"Brain"},{"key":"9324_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2017.10.002","volume":"45","author":"C Pellicano","year":"2017","unstructured":"Pellicano C, Assogna F, Cellupica N et al (2017) Neuropsychiatric and cognitive profile of early Richardson\u2019s syndrome, progressive supranuclear palsy-parkinsonism and Parkinson\u2019s disease. Parkinsonism Relat Disord 45:50\u201356","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"9324_CR12","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mds.27408","volume":"33","author":"M Picillo","year":"2017","unstructured":"Picillo M, Erro R, Cuoco S, Tepedino MF, Manara R, Pellecchia MT, Barone P (2017) MDS PSP criteria in real-life clinical setting: motor and cognitive characterization of subtypes. Mov Disord 33(8):1361\u20131365","journal-title":"Mov Disord"},{"issue":"Pt 6","key":"9324_CR13","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/brain\/awm032","volume":"130","author":"LI Golbe","year":"2007","unstructured":"Golbe LI, Ohman-Strickland PA (2007) A clinical\u00a0rating\u00a0scale\u00a0for progressive supranuclear palsy. Brain 130(Pt 6):1552\u20131565","journal-title":"Brain"},{"issue":"8","key":"9324_CR14","doi-asserted-by":"publisher","first-page":"e22293","DOI":"10.1371\/journal.pone.0022293","volume":"6","author":"CA Payan","year":"2011","unstructured":"Payan CA, Viallet F, Landwehrmeyer BG et al (2011) NNIPPS Study Group. Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS\u2013Parkinson Plus Scale. PLoS One 6(8):e22293","journal-title":"PLoS One"},{"key":"9324_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"The EuroQol Group","year":"1990","unstructured":"The EuroQol Group (1990) EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy 16:199\u2013208","journal-title":"Health Policy"},{"issue":"1","key":"9324_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/sjop.12090","volume":"55","author":"M Kjaergaard","year":"2014","unstructured":"Kjaergaard M, Arfwedson W, Waterloo K, Jorde R (2014) A study of the psychometric properties of the\u00a0Beck\u00a0Depression\u00a0Inventory-II, the Montgomery and \u00c5sberg\u00a0Depression\u00a0Rating Scale, and the Hospital Anxiety and\u00a0Depression\u00a0Scale in a sample from a healthy population. Scand J Psychol 55(1):83\u201389","journal-title":"Scand J Psychol"},{"key":"9324_CR17","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00415-014-7498-1","volume":"261","author":"G Santangelo","year":"2014","unstructured":"Santangelo G, Barone P, Cuoco S, Raimo S, Pezzella D, Picillo M, Vitale C (2014) Apathy in untreated, de novo patients with Parkinson\u2018s disease: validation study of apathy evaluation scale. J Neurol 261:2319\u20132328","journal-title":"J Neurol"},{"issue":"3","key":"9324_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: movement Disorder Society Task Force guidelines. Mov Disord 27(3):349\u2013356","journal-title":"Mov Disord"},{"issue":"2","key":"9324_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mdc3.12582","volume":"5","author":"GU H\u00f6glinger","year":"2018","unstructured":"H\u00f6glinger GU (2018) Is it useful to classify progressive supranuclear palsy and corticobasal degeneration as different disorders? No. Mov Disord Clin Pract 5(2):141\u2013144","journal-title":"Mov Disord Clin Pract"},{"key":"9324_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.08.025","author":"C Brittain","year":"2018","unstructured":"Brittain C, McCarthy A, Irizarry MC et al (2018) Severity dependent distribution of impairments in PSP and CBS: interactive visualizations. Parkinsonism Relat Disord. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2018.08.025","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"9324_CR21","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3233\/JAD-140570","volume":"42","author":"MG Vita","year":"2014","unstructured":"Vita MG, Marra C, Spinelli P et al (2014) Typicality\u00a0of\u00a0words\u00a0produced\u00a0on a\u00a0semantic\u00a0fluency task in amnesic mild cognitive impairment: linguistic analysis and risk of conversion to dementia. J Alzheimers Dis 42(4):1171\u20131178","journal-title":"J Alzheimers Dis"},{"key":"9324_CR22","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1093\/brain\/115.6.1727","volume":"16","author":"AM Owen","year":"1992","unstructured":"Owen AM, James M, Leigh PN et al (1992) Fronto-striatal cognitive deficits at different stages of Parkinson\u2019s disease. Brain 16:1727\u20131751","journal-title":"Brain"},{"issue":"10","key":"9324_CR23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/hbm.20221","volume":"27","author":"SG Costafreda","year":"2006","unstructured":"Costafreda SG, Fu CH, Lee L, Everitt B, Brammer MJ, David AS (2006) A systematic review and quantitative appraisal of fMRI studies of verbal fluency: role of the left inferior frontal gyrus. Hum Brain Mapp 27(10):799\u2013810","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"9324_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1037\/0894-4105.18.2.284","volume":"18","author":"JD Henry","year":"2004","unstructured":"Henry JD, Crawford JR (2004) A meta-analytic review of verbal fluency performance following focal cortical lesions. Neuropsychology 18(2):284\u2013295","journal-title":"Neuropsychology"},{"issue":"5","key":"9324_CR25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/jnnp-2012-303618","volume":"84","author":"T Rittman","year":"2013","unstructured":"Rittman T, Ghosh BC, McColgan P et al (2013) The Addenbrooke\u2019s Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders. J Neurol Neurosurg Psychiatry 84(5):544\u2013551","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9324_CR26","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1590\/1516-4446-2012-1048","volume":"35","author":"YP Wang","year":"2013","unstructured":"Wang YP, Gorenstein C (2013) Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Rev Bras Psiquiatr 35:416\u2013431","journal-title":"Rev Bras Psiquiatr"},{"issue":"1","key":"9324_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1176\/appi.neuropsych.17010012","volume":"30","author":"M Je\u010dmenica-Luki\u0107","year":"2018","unstructured":"Je\u010dmenica-Luki\u0107 M, Pekmezovi\u0107 T, Petrovi\u0107 IN, Tomi\u0107 A, Svetel M, Kosti\u0107 VS (2018) Use of the neuropsychiatric inventory to characterize the course of neuropsychiatric symptoms in progressive supranuclear palsy. J Neuropsychiatry Clin Neurosci 30(1):38\u201344","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"9324_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/mdc3.12382","volume":"4","author":"L Almeida","year":"2017","unstructured":"Almeida L, Ahmed B, Walz R et al (2017) Depressive Symptoms are frequent in atypical parkinsonian disorders. Mov Disord Clin Pract 4(2):191\u2013197","journal-title":"Mov Disord Clin Pract"},{"key":"9324_CR29","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1001\/jamapsychiatry.2013.2224","volume":"70","author":"RS Wilson","year":"2013","unstructured":"Wilson RS, Nag S, Boyle PA et al (2013) Brainstem aminergic nuclei and late-life depressive symptoms. JAMA Psychiatry 70:1320\u20131328","journal-title":"JAMA Psychiatry"},{"key":"9324_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jns.2011.07.006","volume":"310","author":"M Benoit","year":"2011","unstructured":"Benoit M, Robert PH (2011) Imaging correlates of apathy and depression in Parkinson\u2019s disease. J Neurol Sci 310:58\u201360","journal-title":"J Neurol Sci"},{"issue":"6","key":"9324_CR31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000121388","volume":"5","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 5(6):339\u2013346","journal-title":"Neurodegener Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09324-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09324-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09324-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T19:12:27Z","timestamp":1586805147000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09324-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["9324"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09324-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"4 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MP is supported by the Michael J Fox Foundation for Parkinson\u2019s research; PB received consultancies as a member of the advisory board for Zambon, Lundbeck, UCB, Chiesi, Abbvie and Acorda; RE received consultancies from Zambon and honoraria from TEVA; the other authors report no financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}